Skip to main content
AOSSM 2026 Annual Meeting Main banner
ViewAttendees 1

General Session- Pivot Point: Decisions that Define ACL Outcomes

Case Presentations and Panel Q&A

Thursday, July 9, 2026
8:44 AM - 9:10 AM PDT
Location: Level 4, Hall 4C

    Panel Moderator(s)

  • Aaron J. Krych, MD

    Department Chair of Orthopedic Surgery
    Mayo Clinic
    Rochester, MN, US

    Disclosure(s): Arthrex, Inc: Consultant (Ongoing), Royalties (Ongoing)

    • General Session Moderator(s)

  • AB

    Asheesh Bedi, MD

    University of MIchigan Hospitals

    Disclosure(s): Arthrex Inc: Consultant (Ongoing), Royalties (Ongoing)

    • Session Panelist(s)

  • Bert Mandelbaum, MD

    Vice Chair, Professor, Department of Orthopaedic Surgery
    Cedars Sinai Orthopaedics and Sports Medicine
    Santa Monica, CA, United States

    Disclosure(s): APEX Biologix: Consultant (Ongoing); Arthrex: Consultant (Ongoing)

  • Jeffrey R. Dugas, MD

    Fellowship Director
    Andrews Sports Medicine and Orthopedic Center American Sports Medicine Institute
    Birmingham, AL, United States

    Disclosure(s): Arthrex: Researcher (Ongoing), Royalties (Ongoing), Speaker (Ongoing); Smith & Nephew: Researcher (Ongoing); Topical Gear: Own stock options in a privately held ineligible company (Ongoing), Royalties (Ongoing)

  • Elizabeth Matzkin, MD

    Orthopedic Surgeon - Sports Medicine
    Mass General brigham
    Boston, MA, US

    Disclosure(s): Arthrex: Speaker (Ongoing)

  • Walter R. Lowe, MD

    Chairman and Professor
    UTHealth Houston/ Department of Orthopedic Surgery
    Houston, TX, United States

    Disclosure(s): Arthrex, Inc: Consultant (Ongoing), Royalties (Ongoing)

  • Seth L. Sherman, MD

    Stanford University

    Disclosure(s): Allosource: Speaker (Ongoing); Arcuro Medical: Consultant (Ongoing), Paid Advisor (Ongoing); Arthrex: Consultant (Ongoing); ConMed: Royalties (Ongoing); DJO: Royalties (Ongoing); Epicrispr BioTech: Own stock options in a privately held ineligible company (Ongoing); Icarus: Own stock options in a privately held ineligible company (Ongoing); JRF Ortho: Speaker (Ongoing); Kinamed: Speaker (Ongoing); Kyniska Robotics: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing), Paid Advisor (Ongoing); LifeNet Health: Consultant (Ongoing); MIACH: Speaker (Ongoing); MoxImed: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing), Paid Advisor (Ongoing); Octane Biotherapeutics: Speaker (Ongoing); Organogenesis: Speaker (Ongoing); Ossio: Speaker (Ongoing); Reparel: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing), Paid Advisor (Ongoing); Sarcio Inc: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing), Paid Advisor (Ongoing); Smith & Nephew: Speaker (Ongoing); Sparta Biomedical: Consultant (Ongoing), Paid Advisor (Ongoing); Sparta-Bioenthesis: Own stock options in a privately held ineligible company (Ongoing); Vericel: Consultant (Ongoing); Vivorte: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing), Paid Advisor (Ongoing)

Disclosure(s):
Aaron J. Krych, MD: Arthrex, Inc: Consultant (Ongoing), Royalties (Ongoing)
Asheesh Bedi, MD: Arthrex Inc: Consultant (Ongoing), Royalties (Ongoing)
Bert Mandelbaum, MD: APEX Biologix: Consultant (Ongoing); Arthrex: Consultant (Ongoing)
Jeffrey R. Dugas, MD: Arthrex: Researcher (Ongoing), Royalties (Ongoing), Speaker (Ongoing); Smith & Nephew: Researcher (Ongoing); Topical Gear: Own stock options in a privately held ineligible company (Ongoing), Royalties (Ongoing)
Elizabeth Matzkin, MD: Arthrex: Speaker (Ongoing)
Walter R. Lowe, MD: Arthrex, Inc: Consultant (Ongoing), Royalties (Ongoing)
Seth L. Sherman, MD: Allosource: Speaker (Ongoing); Arcuro Medical: Consultant (Ongoing), Paid Advisor (Ongoing); Arthrex: Consultant (Ongoing); ConMed: Royalties (Ongoing); DJO: Royalties (Ongoing); Epicrispr BioTech: Own stock options in a privately held ineligible company (Ongoing); Icarus: Own stock options in a privately held ineligible company (Ongoing); JRF Ortho: Speaker (Ongoing); Kinamed: Speaker (Ongoing); Kyniska Robotics: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing), Paid Advisor (Ongoing); LifeNet Health: Consultant (Ongoing); MIACH: Speaker (Ongoing); MoxImed: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing), Paid Advisor (Ongoing); Octane Biotherapeutics: Speaker (Ongoing); Organogenesis: Speaker (Ongoing); Ossio: Speaker (Ongoing); Reparel: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing), Paid Advisor (Ongoing); Sarcio Inc: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing), Paid Advisor (Ongoing); Smith & Nephew: Speaker (Ongoing); Sparta Biomedical: Consultant (Ongoing), Paid Advisor (Ongoing); Sparta-Bioenthesis: Own stock options in a privately held ineligible company (Ongoing); Vericel: Consultant (Ongoing); Vivorte: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing), Paid Advisor (Ongoing)